Vyant Bio
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.
Show More
CEO
John Roberts
Employees
34
Country
United States
ISIN
US92942V1098
WKN
000A3DZJZ
Listings
0 Comments
Share your thoughts
FAQs
What is Vyant Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Vyant Bio stocks are traded under the ticker 1C8.MU.
How many employees does Vyant Bio have?▼
As of November 2, 2026, the company has 34 employees.
In which sector is Vyant Bio located?▼
Vyant Bio operates in the Health & Wellness sector.
When did Vyant Bio complete a stock split?▼
The last stock split for Vyant Bio was on November 2, 2022 with a ratio of 1:5.
Where is Vyant Bio headquartered?▼
Vyant Bio is headquartered in Rutherford, United States.